Shigeki Ohashi

Director/Miembro de la Junta en ALFRESA HOLDINGS CORPORATION .

61 años

Distribution Services

Health Technology

Commercial Services

Perfil

Shigeki Ohashi is Director & Managing Executive Officer at Alfresa Holdings Corp.
since 2022 and Outside Director at Human Life CORD Japan, Inc. Formerly, Mr. Ohashi was Director at Sannova KK.

Cargos activos de Shigeki Ohashi

Empresas	Cargo	Inicio
ALFRESA HOLDINGS CORPORATION	Director/Miembro de la Junta	01/06/2022
Human Life CORD Japan, Inc Human Life CORD Japan, Inc Miscellaneous Commercial ServicesCommercial Services Engages in research and development, manufacturing and sales of regenerative medicine products	Director/Miembro de la Junta	-

Todos los cargos activos de Shigeki Ohashi

Antiguos cargos conocidos de Shigeki Ohashi.

Empresas	Cargo	Fin
Sannova KK Sannova KK Pharmaceuticals: MajorHealth Technology Engages in research, development, manufacturing, and distribution of pharmaceutical products and skin-care products	Director/Miembro de la Junta	-

Ver el detalle de la experiencia de Shigeki Ohashi.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Shigeki Ohashi.

Relaciones

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas privadas	3
Alfresa Holdings Corp. Alfresa Holdings Corp. Medical DistributorsDistribution Services Distributes pharmaceuticals, diagnostic reagents, and medical devices, as well as manages its subsidiaries that engage in the import and export business	Distribution Services
Sannova KK Sannova KK Pharmaceuticals: MajorHealth Technology Engages in research, development, manufacturing, and distribution of pharmaceutical products and skin-care products	Health Technology
Human Life CORD Japan, Inc Human Life CORD Japan, Inc Miscellaneous Commercial ServicesCommercial Services Engages in research and development, manufacturing and sales of regenerative medicine products	Commercial Services